Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma
zevorcabtagene autoleucel(一种全人源BCMA靶向CAR-T细胞疗法)治疗复发/难治性多发性骨髓瘤患者的II期研究
期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00710-y
Chen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; Jiang, Songfu; Jing, Hongmei; Liu, Jing; Du, Xin; Fu, Rong; Mei, Heng; Zhu, Zunmin; Yang, Yanli; Liu, Hong; Meng, Xingxing; Rajakumaraswamy, Nishanthan; Yuan, Daijing; Wang, Huamao; Li, Zonghai
T细胞
多发性骨髓瘤
T细胞
骨髓瘤
细胞生物学
免疫/内分泌